Fusion Antibodies Plc (FAB.LN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 03/31
| 09-2020 | 03-2020 | 09-2019 | 03-2019 | 09-2018 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 3,243 | 1,537 | 1,313 | 1,984 | 2,803 |
| Inventories | 373 | 340 | 231 | 243 | 96 |
| Other current assets | 1,240 | 925 | 1,239 | 1,079 | 664 |
| TOTAL | $4,856 | $2,802 | $2,783 | $3,306 | $3,562 |
| Non-Current Assets | |||||
| PPE Net | 1,401 | 1,470 | 1,558 | 1,588 | 1,591 |
| Intangibles | 3 | 4 | 5 | 6 | 7 |
| Other Non-Current Assets | 2,045 | 1,764 | 1,488 | 1,342 | 1,277 |
| TOTAL | $3,449 | $3,238 | $3,051 | $2,937 | $2,876 |
| Total Assets | $8,305 | $6,040 | $5,834 | $6,243 | $6,438 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 607 | 415 | 580 | 462 | 522 |
| TOTAL | $768 | $989 | $704 | $796 | $556 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 20 | 20 | 190 | 20 | 20 |
| TOTAL | $168 | $239 | $190 | $93 | $46 |
| Total Liabilities | $936 | $1,228 | $894 | $889 | $602 |
| Shareholders' Equity | |||||
| Common Shares | 1,017 | 884 | 884 | 884 | 884 |
| Retained earnings | -1,183 | -944 | -816 | -402 | 80 |
| TOTAL | $7,369 | $4,812 | $4,940 | $5,354 | $5,836 |
| Total Liabilities And Equity | $8,305 | $6,040 | $5,834 | $6,243 | $6,438 |